Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
922
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China
Kehong Yanga Faculty of Pharmacy, Bengbu Medical College, Bengbu, P.R. China;b School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, Australia
https://orcid.org/0009-0008-4292-3424
Susan Huab School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, Australia
, Wenting Weic Guangdong Cadre Health Management Center, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, P.R. China
, Congyan Yangd The First Affiliated Hospital of Bengbu Medical College, Bengbu, P.R. China
, Xinhai Zhue Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, P.R. China
& Shu Chuen Lib School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, AustraliaCorrespondence[email protected]
Pages 1424-1431
|
Received 18 Aug 2023, Accepted 16 Oct 2023, Published online: 31 Oct 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.